BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24944228)

  • 1. Reaching the london declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa.
    Turner HC; Walker M; Churcher TS; Osei-Atweneboana MY; Biritwum NK; Hopkins A; Prichard RK; Basáñez MG
    Clin Infect Dis; 2014 Oct; 59(7):923-32. PubMed ID: 24944228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data.
    Turner HC; Walker M; Attah SK; Opoku NO; Awadzi K; Kuesel AC; Basáñez MG
    Parasit Vectors; 2015 Mar; 8():167. PubMed ID: 25889256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections.
    Turner HC; Walker M; Churcher TS; Basáñez MG
    Parasit Vectors; 2014 May; 7():241. PubMed ID: 24886747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control.
    Verver S; Walker M; Kim YE; Fobi G; Tekle AH; Zouré HGM; Wanji S; Boakye DA; Kuesel AC; de Vlas SJ; Boussinesq M; Basáñez MG; Stolk WA
    Clin Infect Dis; 2018 Jun; 66(suppl_4):S267-S274. PubMed ID: 29860291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What does the COVID-19 pandemic mean for the next decade of onchocerciasis control and elimination?
    Hamley JID; Blok DJ; Walker M; Milton P; Hopkins AD; Hamill LC; Downs P; de Vlas SJ; Stolk WA; Basáñez MG
    Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):269-280. PubMed ID: 33515042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis.
    Stolk WA; Walker M; Coffeng LE; Basáñez MG; de Vlas SJ
    Parasit Vectors; 2015 Oct; 8():552. PubMed ID: 26489937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?
    Kura K; Milton P; Hamley JID; Walker M; Bakajika DK; Kanza EM; Opoku NO; Howard H; Nigo MM; Asare S; Olipoh G; Attah SK; Mambandu GL; Kennedy KK; Kataliko K; Mumbere M; Halleux CM; Hopkins A; Kuesel AC; Kinrade S; Basáñez MG
    Philos Trans R Soc Lond B Biol Sci; 2023 Oct; 378(1887):20220277. PubMed ID: 37598705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes.
    Dadzie Y; Amazigo UV; Boatin BA; Sékétéli A
    Infect Dis Poverty; 2018 Jul; 7(1):63. PubMed ID: 29966535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial and Economic Costs of the Elimination and Eradication of Onchocerciasis (River Blindness) in Africa.
    Kim YE; Sicuri E; Tediosi F
    PLoS Negl Trop Dis; 2015; 9(9):e0004056. PubMed ID: 26360917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment.
    Coffeng LE; Stolk WA; Hoerauf A; Habbema D; Bakker R; Hopkins AD; de Vlas SJ
    PLoS One; 2014; 9(12):e115886. PubMed ID: 25545677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol.
    Wanji S; Nji TM; Hamill L; Dean L; Ozano K; Njouendou AJ; Abong RA; Obie ED; Amuam A; Ekanya R; Ndongmo WPC; Ndzeshang BL; Fung EG; Nnamdi DB; Nkimbeng DA; Teghen S; Kah E; Piotrowski H; Forrer A; Khan JAM; Woode ME; Niessen L; Watson V; Njoumemi Z; Murdoch ME; Thomson R; Theobald S; Enyong P; Turner JD; Taylor MJ
    Parasit Vectors; 2019 Dec; 12(1):574. PubMed ID: 31801631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost of annual versus biannual community-directed treatment of onchocerciasis with ivermectin: Ghana as a case study.
    Turner HC; Osei-Atweneboana MY; Walker M; Tettevi EJ; Churcher TS; Asiedu O; Biritwum NK; Basáñez MG
    PLoS Negl Trop Dis; 2013; 7(9):e2452. PubMed ID: 24069497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. African Programme for Onchocerciasis Control: progress report, 2013-2014.
    Wkly Epidemiol Rec; 2014 Dec; 89(49):551-60. PubMed ID: 25485343
    [No Abstract]   [Full Text] [Related]  

  • 14. Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.
    Turner HC; Churcher TS; Walker M; Osei-Atweneboana MY; Prichard RK; Basáñez MG
    PLoS Negl Trop Dis; 2013; 7(4):e2169. PubMed ID: 23634234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal.
    Walker M; Stolk WA; Dixon MA; Bottomley C; Diawara L; Traoré MO; de Vlas SJ; Basáñez MG
    Epidemics; 2017 Mar; 18():4-15. PubMed ID: 28279455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can ivermectin mass treatments eliminate onchocerciasis in Africa?
    Winnen M; Plaisier AP; Alley ES; Nagelkerke NJ; van Oortmarssen G; Boatin BA; Habbema JD
    Bull World Health Organ; 2002; 80(5):384-91. PubMed ID: 12077614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative treatment strategies to accelerate the elimination of onchocerciasis.
    Boussinesq M; Fobi G; Kuesel AC
    Int Health; 2018 Mar; 10(suppl_1):i40-i48. PubMed ID: 29471342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost.
    Coffeng LE; Stolk WA; Zouré HG; Veerman JL; Agblewonu KB; Murdoch ME; Noma M; Fobi G; Richardus JH; Bundy DA; Habbema D; de Vlas SJ; Amazigo UV
    PLoS Negl Trop Dis; 2013; 7(1):e2032. PubMed ID: 23383355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An appraisal of the neglected tropical diseases control program in Cameroon: the case of the national program against onchocerciasis.
    Njim T; Aminde LN
    BMC Public Health; 2017 Jan; 17(1):103. PubMed ID: 28109269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.
    Tekle AH; Elhassan E; Isiyaku S; Amazigo UV; Bush S; Noma M; Cousens S; Abiose A; Remme JH
    Parasit Vectors; 2012 Feb; 5():28. PubMed ID: 22313631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.